✦ LIBER ✦

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future

✍ Scribed by Yang, Chih-Hsin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of first-generation tyrosine kin

✍ Riely, Gregory J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

EGFR Inhibitors in Cancer Treatment || C

✍ Ciardiello, Fortunato 📂 Article 📅 2012 🏛 Future Medicine Ltd ⚖ 776 KB

The effect of combination treatment with

✍ C.H. Briggs; C.D. Betts; K.J. O'Flynn; J.V. Moore; N.W. Clarke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 200 KB

13 The predictive value of serum tumour

✍ Pearmain, L.; Crawford, S.M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Searching for a magic bullet in NSCLC: t

✍ Wong, Kwok-Kin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 334 KB

PD-159 Mutation in the tyrosine kinase d

✍ Tsai, C.; Chiu, C.; Chou, T.; Li, L.; Chang, K.; Chen, Y.; Tsai, S.; Perng, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB